Kasper Sobfeldt Jahn

Kasper Jahn joined Novo Holdings in 2014 as part of the Principal Investments team, Novo Holdings’ buyout investment team focusing on healthcare. In 2021, Kasper transitioned to head the Strategy Office, and in 2025 he joined the Executive Leadership Team, also assuming responsibility for People & Organisation.

Before joining Novo Holdings, Kasper was an Engagement Manager for McKinsey & Company in their Copenhagen office. During his time with McKinsey & Company, Kasper primarily served pharmaceutical and medical device companies.

Kasper holds an MSc (2009) and a PhD (2011) in Nanoscience from Aarhus University, and is a CFA® Charterholder.